Description

6-Butyl-1,4-Dihydro-4-Oxo-7-(Phenylmethoxy)Quinoline-3-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate with a complex quinoline carboxylic acid structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular frameworks. It is primarily sought by research institutions and manufacturers in the pharmaceutical and biotechnology sectors engaged in drug discovery and process development.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the research and synthesis of new chemical entities (NCEs) and active pharmaceutical ingredients (APIs).
• Drug Discovery & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization processes.
• Chemical Synthesis Building Block: Utilized in organic synthesis to construct complex quinoline-based heterocyclic compounds.
• Biochemical Research: Employed in academic and industrial research laboratories for investigating enzyme interactions and biological pathways.
• Reference Standard: Acts as a certified reference material (CRM) for analytical method development and quality control in pharmaceutical manufacturing.

Basic Information

Product Name	6-Butyl-1,4-Dihydro-4-Oxo-7-(Phenylmethoxy)Quinoline-3-Carboxylic Acid
CAS No.	94278-93-0
Molecular Formula	C21H21NO4
Molecular Weight	351.40 g/mol
Synonyms	7-(Benzyloxy)-6-butyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid; 6-Butyl-7-(benzyloxy)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; 7-Benzyloxy-6-butyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid; 6-n-Butyl-7-benzyloxy-4-hydroxy-3-quinolinecarboxylic acid; 7-(Phenylmethoxy)-6-butyl-4-hydroxyquinoline-3-carboxylic acid; 6-Butyl-7-(phenylmethoxy)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
EINECS	Contact for details

Quality Control

Our 6-Butyl-1,4-Dihydro-4-Oxo-7-(Phenylmethoxy)Quinoline-3-Carboxylic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specified parameters. Our commitment to quality supports compliance with cGMP and ICH guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed after opening to minimize exposure to atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.